Sandro Matosevic
Immunology and Microbiology · Purdue University West Lafayette
Publications
94
Citations
3,287
Est. group size
~12
Recurring co-author estimate
Active years
20
Publishing since 2007
Sandro Matosevic's research focuses on developing cell-based immunotherapies for cancer, with particular emphasis on engineering natural killer (NK) cells and gene-editing approaches to make immune cells better at recognizing and attacking tumors. Work spans solid tumors such as glioblastoma and osteosarcoma, as well as blood-related and immune signaling mechanisms within the tumor microenvironment. The lab also develops open-source computational tools to support cell-based research.
Publication output grew from 2017 through a peak around 2020-2021, dipped notably in 2024, and rebounded in 2025-2026, suggesting a generally active but somewhat variable publishing pace over the past decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cells
Med · 2026
- Immunosuppressive Tumor Microenvironment and Therapeutic Landscape of Diffuse Intrinsic Pontine Glioma
Medicinal Research Reviews · 2026
- Open Source CellSeekr Codebase
Zenodo (CERN European Organization for Nuclear Research) · 2026
- Open Source CellSeekr Codebase
Zenodo (CERN European Organization for Nuclear Research) · 2026
- The diversity of natural killer cell functional and phenotypic states in cancer
Cancer and Metastasis Reviews · 2025
- Pathology, immunosuppression and NK cell immunotherapy of non-small cell lung cancer
Critical Reviews in Oncology/Hematology · 2025
- Afamitresgene autoleucel: first cell therapy for synovial sarcoma
Trends in Pharmacological Sciences · 2025
- Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance
Cancer Gene Therapy · 2025
- The differential regulation of the urea cycle in tumors goes awry
Biochemical Pharmacology · 2025
- Meeting HighlightsThe 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations
Wiadomości Lekarskie · 2025
- 1020 Simultaneous targeting of malignant and immunosuppressive cells by engineered natural killer cells as immunotherapy against osteosarcoma
Regular and Young Investigator Award Abstracts · 2025
- 1018 Stable BaEVTR-based system enhances retroviral engineering of NK cells for CAR delivery via SLC1A5-mediated uptake
Regular and Young Investigator Award Abstracts · 2025
- Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses
Molecular Pharmaceutics · 2024
- Generation and evaluation of cancer binding capacity of HLA-A2-WT1 complex-targeting antibody
Immunology Letters · 2024
- 998 Identification of the role of oncometabolites on natural killer cell in the tumor microenvironment by CRISPR screening
Regular and Young Investigator Award Abstracts · 2023
- Regular and Young Investigator Award Abstracts×21
- Elsevier eBooks×6
- Frontiers in Immunology×4
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Cancers×2
- Kyle B. Lupo
Immunology and Microbiology · Purdue University West Lafayette
- Shambhavi Borde
Immunology and Microbiology · Purdue University West Lafayette
- Jianhua Yu
Immunology and Microbiology · The Ohio State University
- Dean A. Lee
Immunology and Microbiology · The Ohio State University
- Jilu Zhang
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile